OptimizeRx

OptimizeRx Current Liabilities

The Current Liabilities of OptimizeRx (OPRX) as of Oct 9, 2026 is 20.76 M USD. In the previous year, Current Liabilities was 28.52 M USD — a change of -27.20% (lower).

Current Liabilities

20.76 MUSD

YoY

-27.20%

Last updated:

Current Liabilities of OptimizeRx is 2025 20.76 M USD. Current Liabilities of OptimizeRx was 2024 28.52 M USD. It decreases by -27.20% lower compared to the previous year.

The OptimizeRx Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
4.92 M USD
Jan 1, 2019
7.43 M USD
Jan 1, 2020
12.24 M USD
Jan 1, 2021
10.98 M USD
Jan 1, 2022
10.93 M USD
Jan 1, 2023
27.64 M USD
Jan 1, 2024
28.52 M USD
Jan 1, 2025
20.76 M USD
The OptimizeRx Current Liabilities history
YEARCurrent LiabilitiesYoY
20.76 MUSD-27.20%
28.52 MUSD+3.18%
27.64 MUSD+152.82%
10.93 MUSD-0.43%
10.98 MUSD-10.32%
12.24 MUSD+64.83%
7.43 MUSD+50.95%
4.92 MUSD-5.61%
5.21 MUSD-14.19%
6.08 MUSD+10.45%
5.50 MUSD+44.70%
3.80 MUSD-12.16%
4.33 MUSD+500.01%
721,270.00USD-32.76%
1.07 MUSD+70.51%
629,109.00USD+1,562.99%
37,830.00USD-82.63%
217,797.00USD-35.92%
339,892.00USD—
Access this data via the Eulerpool API
Get Free API Key

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

Current Liabilities of OptimizeRx is 20.76 M USD in 2025.

Current Liabilities of OptimizeRx changed from 28.52 M USD to 20.76 M USD, representing a -27.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities OptimizeRx since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's OptimizeRx historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — OptimizeRx

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — OptimizeRx